BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31845824)

  • 1. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
    Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
    Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
    Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
    Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
    Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
    J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
    Zhou X; Wu C; Cheng Q
    Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
    Fan Y; Du Y; Sun W; Wang H
    Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 12. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
    Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
    Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.